stella
beta
Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH) — Stella
Home
/
Stargardt Disease
/
Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
View on ClinicalTrials.gov
Recruiting
Back to Stargardt Disease trials
Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
Trial locations
(8 sites)
United States
University of San Francisco, San Francisco, California
Vitreo Retinal Associates, Gainesville, Florida
Wilmer Eye Institute at John Hopkins, Baltimore, Maryland
Massachusetts Eye and Ear, Boston, Massachusetts
University of Michigan Kellogg Eye Center, Ann Arbor, Michigan
Cincinnati Eye Institute, Cincinnati, Ohio
Retina Foundation of Texas, Dallas, Texas
Retina Consultants of Texas, Houston, Texas